Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3949/ccjm.91.s1.06 http://scihub22266oqcxt.onion/10.3949/ccjm.91.s1.06 39231600!ä!39231600 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=39231600&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\39231600.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Cleve+Clin+J+Med 2024 ; 91 (9 suppl 1): S34-S41 Nephropedia Template TP {{tp|p=39231600|t=2024. RSV in transplant and immunocompromised patients |pdf=|usr=}}{{39231600}} gab.com Text RSV in transplant and immunocompromised patients JO: Cleve Clin J Med http://www.kidney.de/pget.php?&tw=1&pmid=39231600 #FOAvip Respiratory syncytial virus (RSV) is a significant cause of morbidity and mortality in infants, older adults, and patients with weakened immune systems. Disease severity differs by underlying immunologic pathologies, with worse outcomes associated with progression from upper to lower respiratory disease. In this review we address the impact of RSV in immunocompromised populations, and discuss the limited available treatments and the potential impact of newer RSV prevention strategies on immunocompromised adults and children. Twit Text FOAVip RSV in transplant and immunocompromised patients ????Cleve Clin J Med http://www.kidney.de/pget.php?&tw=1&pmid=39231600 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=39231600 #FOAvip English Wikipedia <ref>{{Cite pmid|39231600}}</ref> RSV in transplant and immunocompromised patients #MMPMID39231600 Koval CE; Gonzalez BE Cleve Clin J Med 2024[Sep]; 91 (9 suppl 1): S34-S41 PMID39231600show ga Respiratory syncytial virus (RSV) is a significant cause of morbidity and mortality in infants, older adults, and patients with weakened immune systems. Disease severity differs by underlying immunologic pathologies, with worse outcomes associated with progression from upper to lower respiratory disease. In this review we address the impact of RSV in immunocompromised populations, and discuss the limited available treatments and the potential impact of newer RSV prevention strategies on immunocompromised adults and children. |*Immunocompromised Host[MESH] |*Respiratory Syncytial Virus Infections/immunology/prevention & control[MESH] |Adult[MESH] |Antiviral Agents/therapeutic use[MESH] |Child[MESH] |Humans[MESH]RSV in transplant and immunocompromised patients (epmc).pdf DeepDyve Pubget Overpricing